Taysha Gene Therapies Inc (TSHA)

CapEx to Revenue

61.64%

TTM · Retrieved:

TSHA logo

TSHA CapEx to Revenue

Current (TTM)61.64%
TSHA CapEx/Revenue (0.00% → 61.64%)
High-resolution chart · PNG

TSHA capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Taysha Gene Therapies Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.5514%
4.4882%
47.6927%
993.9648%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.